approval
saveAMJEVITA (ADALIMUMAB-ATTO) — FDA approval
community read0 votes
Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalOct 16, 2025 · 350d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalSep 17, 2025 · 379d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalApr 7, 2025 · 542d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalAug 20, 2024 · 772d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalAug 14, 2023 · 1144d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalJul 12, 2023 · 1177d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalApr 6, 2023 · 1274d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalMar 22, 2023 · 1289d ago
same company · ±60 days · 6
- approvalblinatumomab: BLINCYTO (BLINATUMOMAB) — FDA approvalApr 29, 2025
- approvalENBREL (ETANERCEPT) — FDA approvalJun 18, 2025
- approvaleculizumab biosimilar: BKEMV (ECULIZUMAB-AEEB) — FDA approvalApr 18, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalApr 7, 2025
- recallAmgen, Inc. recall (Cls II)Mar 26, 2025
- recallAmgen, Inc. recall (Cls II)Mar 26, 2025
🐶 often sniffed alongside
top 8- tagApproval214 co-mentions · 94 sources
- drugHUMIRA188 co-mentions · 94 sources
- drugadalimumab168 co-mentions · 94 sources
- drugYUSIMRY81 co-mentions · 81 sources
- drugABRILADA81 co-mentions · 81 sources
- company$ABBVAbbVie Inc.61 co-mentions · 61 sources
- company$AMGNAMGEN INC26 co-mentions · 13 sources
- drugCYLTEZO24 co-mentions · 12 sources
comments(0)
5-min edit window · permanent after that